Pharmacotherapy of plexiform neurofibromas in patients with neurofibromatosis type 1. Possible adverse events and their management
Neurofibromatosis type 1 is a multisystem genetic disorder associated with an increased risk of benign and malignant tumors due to mutations in the NF1 gene. Clinical manifestations of the disease vary and depend on the patient’s age. One of the most common complications of neurofibromatosis type 1...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2024-07-01
|
Series: | Русский журнал детской неврологии |
Subjects: | |
Online Access: | https://rjdn.abvpress.ru/jour/article/view/471 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|